Litcius/Paper detail

Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer

Dig Bijay Mahat, Heena Kumra, Sarah A Castro, Emily Metcalf, Kim B. Nguyen, Ryo Morisue, William W. Ho, Ivy Chen, Brandon M. Sullivan, Leon Yim, Arundeep Singh, Jiayu Fu, Sean K. Waterton, Yu‐Chi Cheng, Enrico Moiso, Vikash P. Chauhan, Hernandez Moura Silva, Stefani Spranger, R. K. Jain, Phillip A. Sharp

2025Immunity25 citationsDOIOpen Access PDF

Topics & Concepts

BiologyPancreatic cancerCancer researchChemokineImmune systemEnhancerMutantImmune checkpointCancerImmunologyImmunotherapyGene expressionGeneticsGenePancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersCancer-related Molecular Pathways